Eli Lilly (LLY.N) expects revenue to be between $58 billion and $61 billion in 2025, compared with a market estimate of $58.72 billion; revenue growth in 2025 is expected to come from new drugs JAYPIRCA, EBGLYSS, OMVOH and KISUNLA.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.
Weekly Highlights